Dan Paterson

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

3 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Global Markets & Equities 15 Oct 2026, 02:19 PM IST

Verastem Says Early RAS Drug Data Set a New Bar in Pancreatic Cancer

Verastem Oncology says early clinical data for its KRAS G12D-targeting drug showed responses in pancreatic cancer, a notoriously difficult disease with few effective options. The update comes as the company raises capital and advances the program toward a pivotal phase III study, sharpening investor focus on whether the drug can emerge as a meaningful competitor in one of oncology’s most competitive races.

By RDU Global Wire5 min read

Global Health & Biotech15 Oct 2026, 08:30 AM IST

Verastem Says Early RAS Data Sets New Benchmark as It Raises $250 Million

Verastem Oncology said early clinical data for its RAS-targeted cancer drug has established a new benchmark in a difficult-to-treat tumor type, a claim that could sharpen investor focus on the company’s pancreatic cancer strategy. The announcement came alongside a $250 million equity financing, giving the biotech fresh capital to advance its pipeline while it seeks to convert preliminary signals into a credible late-stage franchise.

5 min readRead →

Global Markets & Equities15 Oct 2026, 06:47 AM IST

Verastem Says Early RAS Drug Data Sets New Bar as It Raises $250 Million

Verastem Oncology is pitching its early pancreatic cancer data as a potential benchmark-setting readout in one of oncology’s most difficult markets, with chief executive Dan Paterson saying the company’s RAS-targeted program has delivered encouraging signs. The disclosure comes alongside a $250 million equity raise, underscoring both the scientific promise and the capital intensity of advancing a late-stage cancer pipeline.

5 min readRead →

👤 About this Entity

Political leaders, ministers, corporate executives, judges, athletes and creators. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Dan Paterson:

Washington, D.C.(3)Verastem Oncology(3)